Financials

  • Market Capitalization 4.57 M
  • Employee 13
  • Founded 1981
  • CEO Eric A. Adams
  • Website www.inmedpharma.com
  • Headquarter British Columbia, Canada
  • FIGI BBG000BT4589
  • Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-0.39
Price to sales ratio
0.64

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
4947
ADXN
Addex Therapeutics Ltd - American Depositary Shares
3.84 USD-0.26%-16.34%-33.79%-52.53%4.73 M USD
4950
CLGN
CollPlant Biotechnologies Ltd. - Ordinary Shares
0.36 USD+24.14%+9.09%+12.50%-86.05%4.61 M USD
4959
CANF
Can-Fite Biopharma Ltd American Depositary Shares, each represe
3.37 USD-0.59%-0.59%+4.66%-22.62%4.41 M USD
4964
ELAB
PMGC Holdings Inc. - Common Stock
5.31 USD-8.92%-22.48%+510.34%+291.88%4.30 M USD

Frequently asked questions about InMed Pharmaceuticals Inc. Common Shares

What is the InMed Pharmaceuticals Inc. Common Shares stock price today?

The current price of InMed Pharmaceuticals Inc. Common Shares (INM) is 1.38. Over the past 24 hours, the stock has changed by -3.50%. Follow the INM chart for real-time price dynamics.

What is the stock ticker of InMed Pharmaceuticals Inc. Common Shares?

InMed Pharmaceuticals Inc. Common Shares trades under the ticker INM. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is InMed Pharmaceuticals Inc. Common Shares stock going up?

INM has changed by -6.76% over the last week, -17.37% over the last month, and -35.51% over the last year. Review the chart to see whether the current move is part of a broader trend.

What is the market capitalization of InMed Pharmaceuticals Inc. Common Shares?

InMed Pharmaceuticals Inc. Common Shares currently has a market capitalization of 4.57 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.

What were InMed Pharmaceuticals Inc. Common Shares earnings last quarter?

Last quarter, InMed Pharmaceuticals Inc. Common Shares reported earnings of -0.73 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.

What was InMed Pharmaceuticals Inc. Common Shares revenue for the last quarter?

InMed Pharmaceuticals Inc. Common Shares reported quarterly revenue of -23.17 K. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.

What was InMed Pharmaceuticals Inc. Common Shares net income for the last quarter?

InMed Pharmaceuticals Inc. Common Shares reported net income of -2.97 M for the last quarter. The previous quarter showed -2.03 M, which means net income changed by -46.25%.

How many employees does InMed Pharmaceuticals Inc. Common Shares have?

As of the latest available data, InMed Pharmaceuticals Inc. Common Shares has 13 employees. Workforce size can provide additional context about the company's scale and operations.

What is InMed Pharmaceuticals Inc. Common Shares EBITDA?

InMed Pharmaceuticals Inc. Common Shares EBITDA is -2.81 M, and its EBITDA margin is 12.14 K%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy InMed Pharmaceuticals Inc. Common Shares stock?

You can buy InMed Pharmaceuticals Inc. Common Shares (INM) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in InMed Pharmaceuticals Inc. Common Shares stock?

Investing in InMed Pharmaceuticals Inc. Common Shares requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the INM chart and related analysis on metatrader.com as part of your research.

News